GSK to acquire Affinivax Inc. in a multi-billion dollar deal
LONDON, UK: GSK plc (LSE: GSK) has entered into a definitive agreement to acquire Affinivax Inc., a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1 billion upfront payment and up to $1.2 billion in potential development milestones….